Langrehr, J M <br/><br/>
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.  [electronic resource] 

 -  Transplantation proceedings  May 2001 
 - 2330-1 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(01)02011-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antilymphocyte Serum--therapeutic use<br/>Azathioprine--therapeutic use<br/>Bacterial Infections--epidemiology<br/>Cytomegalovirus Infections--epidemiology<br/>Drug Therapy, Combination<br/>Follow-Up Studies<br/>Graft Rejection--epidemiology<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Liver Transplantation--immunology<br/>Muromonab-CD3--therapeutic use<br/>Mycoses--epidemiology<br/>Postoperative Complications--epidemiology<br/>Prednisolone--therapeutic use<br/>Prospective Studies<br/>Sepsis--epidemiology<br/>Survival Rate<br/>Tacrolimus--adverse effects<br/>Time Factors